Back to 
JPMorgan Chase & Co.
JPMorgan Chase & Co.
SNOA
8 quarters
Position history for JPMorgan Chase & Co.'s holdings in Sonoma Pharmaceuticals, Inc.
No. JPMorgan Chase exited its SNOA (Sonoma Pharmaceuticals) position in Q2 2026. Its Q1 2026 13F listed 123 shares worth $255. JPMorgan Chase already held SNOA in its Q3 2024 13F, the earliest on record, and held it in 7 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$424
Total Shares Change
-138
Quarter-by-Quarter History
Other major holders of SNOA: Vanguard Group Inc., Geode Capital Management, LLC, Renaissance Technologies LLC